Últimas noticias sobre Carbon Revolution (NASDAQ:CREV) Bolsa

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Carbon Revolution

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMPG

AVGR

BIPC

CHEK

CREV

FDSB

HSDT

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TIVC

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Earnings

LMNR

VENU

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: NEUE, SIF, CREV, LMNR y VENU.

5 acciones en el foco este martes: NEUE, SIF, CREV, LMNR y VENU

Carbon Revolution Public Limited Company - Ordinary Shares

Carbon Revolution PLC

Carbon Revolution Ltd Ordinary Shares

Carbon Revolution Public Limited Company - Warrant

Oppenheimer analyst Rick Schafer maintains Monolithic Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) with a Outperform and lowers the price target from $900 to $800.

Price Target

Analyst Ratings

MPWR

Oppenheimer Maintains Outperform on Monolithic Power Systems, Lowers Price Target to $800

RBC Capital analyst Walter Spracklin maintains Canadian National Railway (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNR#TSX">CNR</a>) with a Outperform and lowers the price target from C$174 to C$171.

TSX:CNR

RBC Capital Maintains Outperform on Canadian National Railway, Lowers Price Target to C$171

Oppenheimer analyst Bryan Blair reiterates Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) with a Outperform and raises the price target from $220 to $225.

Reiteration

Oppenheimer Reiterates Outperform on Dover, Raises Price Target to $225

JP Morgan analyst Samik Chatterjee maintains Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Neutral and raises the price target from $38 to $45.

CALX

JP Morgan Maintains Neutral on Calix, Raises Price Target to $45

Alcoa's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) short percent of float has risen 10.32% since its last report. The company recently reported that it has 9.09 million shares sold short, which is 4.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.1 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Alcoa Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738345524_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Alcoa has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Alcoa's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Alcoa's peer group average for short interest as a percentage of float is 3.83%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Alcoa's Recent Short Interest

AptarGroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has fallen 3.74% since its last report. The company recently reported that it has 606 thousand shares sold short, which is 1.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.14 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738345518_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AptarGroup has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 4.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About AptarGroup?

Burlington Stores's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) short percent of float has fallen 18.86% since its last report. The company recently reported that it has 2.10 million shares sold short, which is 4.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Burlington Stores Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738345512_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Burlington Stores has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Burlington Stores's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Burlington Stores's peer group average for short interest as a percentage of float is 12.10%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BURL

Looking Into Burlington Stores's Recent Short Interest

Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a <a target="_blank" href="https://www.benzinga.com/quote/CL/analyst-ratings" rel="noreferrer noopener">price forecast of $106.</a>
CL reported fourth-quarter earnings per share of $0.91, surpassing expectations (compared to the GS/FactSet consensus of $0.88/$0.89).
However, fourth-quarter organic sales growth of 4.3% fell short of predictions, impacted by a 50 basis point drag from lower private label volumes in Pet Nutrition, said the analyst.
Additionally, Hill&#8217;s Pet Nutrition faced challenges in Europe, leading to a miss in segment growth.
North America&#8217;s organic sales declined by 0.7%, while Europe and APAC experienced low-to-mid single-digit growth. Latin America and Africa/Eurasia saw high single-digit increases, opined the analyst.
Weaker organic sales growth, combined with higher-than-expected inflationary pressures, contributed to lower-than-anticipated gross margins and slightly weaker operating margins.
Also Read: <a href="https://www.benzinga.com//node/43316332">What&#8217;s In The Cards For Walmart This Earnings Season?</a>
According to the analyst, lower tax rate of 21.6% provided a $0.04 EPS boost, contributing to CL&#8217;s small EPS beat for the quarter.
Management has provided its initial FY25 guidance, which largely aligns with expectations, although foreign exchange headwinds are expected to impact net sales and possibly EPS for the year, per the analyst.
The analyst asserted that the company&#8217;s organic sales growth forecast of 3%—5% is consistent with its long-term target. This guidance accounts for the planned exit from private label pet nutrition in 2025, which is expected to have a larger impact than in the fourth quarter.
Overall, the analyst expects the stock to see modest declines due to weaker-than-expected organic sales growth.
The analyst considers CL one of the top-tier companies in the HPC coverage, consistently outperforming and raising its FY24 outlook, even amidst challenging market conditions.
After three years of strong growth, the analyst anticipates a more balanced environment in FY25 with slower price growth and improved volume/mix trends.
However, foreign exchange remains a potential risk, likely impacting gross margins and dollar EPS growth. Looking ahead, the analyst expects the company to maintain healthy revenue growth driven by favorable market trends and market share expansion, benefiting from household penetration and premiumization.
Price Action: CL shares are trading lower by 4.33% at $86.95 at the last check Friday.
Photo via Shutterstock.

Analyst Color

Equities

General

Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs

WIIM

Corning shares are trading higher. The stock may be moving on continued strength after HSBC upgraded the stock yesterday from Hold to Buy and raised its price target on the stock from $51 to $60.

STMicroelectronics NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) is <a target="_blank" href="https://www.benzinga.com/topic/stmicroelectronics" rel="noreferrer noopener">considering downsizing its</a> workforce in Italy and France by up to 6%, implying 2,000-3,000 workers.
On Thursday,&nbsp;STMicroelectronics <a target="_blank" href="https://www.benzinga.com/25/01/43334149/stmicroelectronics-q4-earnings-22-revenue-drop-sees-challenges-ahead-with-lower-industrial-and-auto-demand" rel="noreferrer noopener">reported fourth-quarter</a> net revenues of $3.32 billion, up by 22.4%, topping the&nbsp;analyst estimate of $3.31 billion. EPS of $0.37&nbsp;missed&nbsp;the&nbsp;analyst estimate of $0.38.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/01/43352019/amazon-cuts-more-jobs-in-cost-saving-push-report" rel="noreferrer noopener">Amazon Cuts More Jobs in Cost-Saving Push: Report</a>
Gross margin plunged 780&nbsp;bps to 37.7% owing to product mix. Operating margin fell by 1,280 bps to 11.1%.
STMicro, which is a supplier to big tech like Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and&nbsp;Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), is grappling with a demand slump in the industrial and auto sectors.
The Italian government, which together with France holds a 27.5% stake in the company seeks to limit the restructuring&#8217;s impact on the Italian workforce, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-01-31/stmicro-eyes-workforce-cuts-of-up-to-6-as-chip-slump-drags-on?sref=TBDibEcD" rel="noreferrer noopener">reported</a>, citing unnamed sources familiar with the matter.
STMicroelectronics expects first-quarter revenue of $2.51 billion, below the analyst estimate of $2.76 billion. STMicroelectronics on Thursday called 2024 one of the industry&#8217;s worst years in decades.
ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) flagged weak demand in <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42958251/on-semi-sees-utilization-cuts-as-ev-demand-softens-analyst-warns" rel="noreferrer noopener">auto and industrial markets</a>, with fab utilization likely to plummet below 65%.
<h2 class="wp-block-heading">STM Stock Prediction For 2025</h2>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of STMicroelectronics have an average 1-year price target of $30.5, representing an expected upside of 33.45%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on STMicroelectronics, while 2 analysts have bullish ratings. The street high price target from Susquehanna is $33.0, while the street low from Susquehanna is $28.0.
Price Action: STM stock traded higher by 1.53% to $22.87 at the last check on Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43298802/arm-china-eyes-leadership-change-ai-boom-and-us-china-chip-wars-reshape-the-industry" target="_blank" rel="noreferrer noopener">Arm China Eyes Leadership Change As AI Boom And US-China Relationship Reshape Industry</a></li>
</ul>
Photo by Michael Vi via Shutterstock

Tech

Media

AAPL

TSLA

Apple And Tesla Supplier STMicroelectronics Plans Up to 3,000 Job Cuts in Italy and France

On CNBC, Stephanie Link Announced Bought More Eaton

JP Morgan analyst Matthew Boss maintains Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) with a Overweight and raises the price target from $200 to $209.

BOOT

JP Morgan Maintains Overweight on Boot Barn Holdings, Raises Price Target to $209

Imperial Oil shares are trading lower after the company reported Q4 financial results and missed its EPS and sales estimates.

Oppenheimer analyst Michael Wiederhorn maintains Cigna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) with a Outperform and lowers the price target from $400 to $375.

Oppenheimer Maintains Outperform on Cigna, Lowers Price Target to $375

MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) continues its bold Bitcoin strategy with a new $563.4 million preferred stock offering, signaling unwavering confidence in <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43201211/microstrategy-to-redeem-105b-in-convertible-notes-settles-conversions-with-shares">the apex crypto</a>.
The company <a href="https://www.microstrategy.com/press/microstrategy-announces-pricing-of-strike-preferred-stock-offering-strk_01-31-2025">announced</a> on Friday that it has priced 7,300,000 shares of 8.00% Series A Perpetual Strike Preferred Stock at $80.00 per share, with settlement expected on Feb. 5.
According to the press release, MicroStrategy intends to use the net proceeds &#8220;for general corporate purposes, including the acquisition of bitcoin and for working capital.&#8221; 
Also Read:<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43396466/grayscale-introduces-dogecoin-trust-for-institutional-investors"> Grayscale Introduces Dogecoin Trust For Institutional Investors</a>
Why It Matters: This move aligns with the company&#8217;s ongoing strategy of leveraging its market position to accumulate more Bitcoin.
The preferred stock offering comes on the heels of MicroStrategy&#8217;s recent Bitcoin buying spree. 
The company acquired an additional 10,107 Bitcoin this week, extending its buying spree to <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43201211/microstrategy-to-redeem-105b-in-convertible-notes-settles-conversions-with-shares">twelve consecutive week</a>s and bringing its total holdings to 471,107 BTC. 
This latest purchase was made at an average cost of $105,596 per Bitcoin, adjusting the company&#8217;s overall cost basis to $64,511 per coin.
MicroStrategy&#8217;s aggressive Bitcoin accumulation strategy has drawn both praise and scrutiny from analysts. 
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43333849/microstrategy-is-a-lever-for-the-believer-says-mizuho-initiates-coverage-on-bitcoins-levered-play-with-an-outperform-rating">Mizuho recently initiated</a> coverage on the company with an &#8216;outperform&#8217; rating and a $515 price target, describing it as a &#8220;Lever for the Believer&#8221; in Bitcoin. 
However, concerns persist about the sustainability of MicroStrategy&#8217;s premium valuation over its Bitcoin holdings.
The company&#8217;s shareholders recently approved a significant increase in authorized stock, potentially fueling further Bitcoin purchases. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43393680/elon-musks-father-launches-musk-it-meme-coin-to-fund-new-think-tank">Elon Musk&#8217;s Father Launches &#8216;Musk It&#8217; Meme Coin To Fund New Think Tank</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

MSTR

MicroStrategy Prices Preferred Stock Offering At $80 Per Share, Seeks $563M To Buy Bitcoin

Cigna Group inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) shares are rebounding Friday after dropping on Thursday following a <a href="https://www.benzinga.com/news/earnings/25/01/43337308/cigna-stock-dives-on-q4-earnings-miss-we-are-taking-corrective-actions-to-address-these-near-term-pressures">fourth-quarter earnings miss</a>.
What To Know: Cigna reported fourth-quarter revenue of $65.68 billion, exceeding analyst estimates of $63.36 billion, but missed on earnings with an adjusted EPS of $6.64 versus expectations of $7.82. The earnings shortfall was driven by higher stop-loss medical costs, which contributed to an 8% decline in adjusted income from operations.
Despite the earnings miss, revenue grew 27% year-over-year, led by increases in pharmacy benefit services and specialty care. The company also announced a $6 billion increase to its share repurchase program, bringing total authorization to $10.3 billion.
Cigna provided 2025 guidance, expecting at least $252 billion in revenue, slightly above estimates. However, full-year adjusted EPS guidance of at least $29.50 fell short of analysts&#8217; expectations of $31.50.
Shares initially dropped 11.1% on Thursday but are rebounding potentially as investors focus on management's corrective actions and long-term strategy.
CI Price Action: Cigna Group shares were up 4.97% at $297.04 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="530" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31120701/Screenshot-2025-01-31-at-12.06.30-1024x530.png" alt="" class="wp-image-760645" style="width:491px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31120701/Screenshot-2025-01-31-at-12.06.30-1024x530.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31120701/Screenshot-2025-01-31-at-12.06.30-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31120701/Screenshot-2025-01-31-at-12.06.30-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31120701/Screenshot-2025-01-31-at-12.06.30.png 1167w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43396598/alphabet-shares-are-on-the-rise-today-whats-going-on">Alphabet Shares Are On The Rise Today: What&#8217;s Going On?</a></li>
</ul>
Image Via Shutterstock.

Cigna Group Shares Are On The Rise Friday: What's Going On?

Oppenheimer analyst Ittai Kidron maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and raises the price target from $300 to $380.

TEAM

Oppenheimer Maintains Outperform on Atlassian, Raises Price Target to $380

RBC Capital analyst Walter Spracklin maintains Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) with a Outperform and lowers the price target from $174 to $171.

RBC Capital Maintains Outperform on Canadian National Railway, Lowers Price Target to $171

JP Morgan analyst Kenneth Worthington maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Neutral and raises the price target from $149 to $154.

JP Morgan Maintains Neutral on Blackstone, Raises Price Target to $154

Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) shares were climbing in on Friday, after having tanked in the previous trading session following the release of the company's <a href="https://www.benzinga.com/25/01/43335926/comcast-q4-earnings-beats-estimates-peacock-subscribers-surge-29-dividend-raised-15-billion-buyback-approved">fourth-quarter results</a>.
The company reported its quarterly results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<h1 class="wp-block-heading">BofA Securities On Comcast</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6422c89f5ce4fa00014ff23b/jessica-reif%20ehrlich">Analyst Jessica Reif Ehrlich</a> downgraded the rating from Buy to Neutral, while slashing the price target from $50 to $38.
Comcast continues to lose broadband market share amid a competitive environment "with still ramping FWA deployments and accelerating fiber builds," Reif Ehrlich said in the downgrade note. The U.S. broadband market has significantly matured, resulting in limited industry growth going ahead, she added.
The company's guidance for ARPU (average revenue per user) growth shows a softening to 3%-4%, "as it leans in converged (i.e. discounted) offerings," the analyst stated. "Peacock requires increased investment which will continue to be a drag on results," she further wrote.
<h1 class="wp-block-heading">Benchmark On Comcast</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ca96e4b85e930001f446dd/matthew-harrigan">Analyst Matthew Harrigan</a> reaffirmed a Buy rating while reducing the price target to $55.
Comcast's stock tanked on Thursday after the company's broadband unit growth missed expectations again, Harrigan said. The stock was also impacted by President Michael Cavanaugh suggesting that Xfinity "could retreat from its 3%-4% broadband pricing collar if highly desirable to support a new connectivity bundled approach with greater emphasis on mobile," he added.
The implied valuation of Connectivity &amp; Platforms based on Comcast's current share price suggests the loss of 1.25 million broadband customers annually "with a complete absence of pricing power," the analyst stated.
<h1 class="wp-block-heading">Goldman Sachs On Comcast</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a1c4e20efacff00015a984c/michael-ng">Analyst Michael Ng</a> reiterated a Buy rating while cutting the price target from $50 to $44.
Comcast's consolidated revenue of $31.9 billion came in ahead of the consensus of $31.6 billion, with adjusted earnings of 96 cents per share topping expectations of 86 per share, Ng said in a note. Management raised the dividend by eight cents to $1.32 per share for 2025 and the board approved a new share repurchase authorization of $15 billion, he added.
"CMCSA is now more aggressively using wireless as a tool to drive subscriber acquisition and retention resulting in near-term margin headwinds from elevated direct product costs, marketing, and ARPU headwinds," the analyst stated. The company's domestic broadband net additions could contract by 496,000 in 2025 and ARPU growth comes in at 3.0%, the low-end of the 3%-4% guidance range, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Oppenheimer On Comcast</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59282ae6290fa7000185325b/timothy-horan">Analyst Timothy Horan</a> maintained an Outperform rating and price target of $55.
Comcast's strong fourth-quarter results were "largely overshadowed by weak subscriber growth, Content &amp; Experiences EBITDA guidance, and management not reiterating broadband ARPU growth of 3%-4%," Horan said. The company would find it difficult to grow revenue and EBITDA in 2025, given tough comps and investments in Theme Parks and Studios, he added.
Management plans to launch more aggressive promotions and pricing to stem the loss of share in broadband, the analyst stated. This is a risk to the Connectivity &amp; Platforms revenues and margins, he further said.
<h1 class="wp-block-heading">Scotiabank On Comcast</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a53c034adcfa70001c2b366/maher-yaghi">Analyst Maher Yaghi</a> reiterated a Sector Outperform rating and price target of $48.
Comcast reported strong quarterly results but faced "continued pressure on broadband loading," Yaghi said. Although the company's subscriber losses in the fourth quarter were within expectations, "the stock is likely to remain pressured until those trends begin to revert," he added.
Given its strong balance sheet, Comcast is returning "significant capital to shareholders," with a large share repurchase plan, the analyst stated. "We believe the company is well positioned to continue to invest in its networks, but until we see a sustainable recovery in broadband subscriber additions, valuation multiples will likely be hard to expand," he further wrote.
<h2 class="wp-block-heading">Rosenblatt Securities On Comcast</h2>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586cf168351b9b0001a3054e/barton-crockett">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586cf168351b9b0001a3054e/barton-crockett">Barton Crockett</a> reaffirmed a Neutral rating on the stock.
Comcast's revenues grew by 2% year-on-year to $31.9 billion, while adjuste4d EBITDA rose 10% to $8.8 billion, Crockett said. Both topped consensus by around $300 million, he added.
The decline in the stock was the biggest single-day loss in over five years, the analyst stated. This was due to a steeper decline in broadband subscribers than was feared as well as the softening of ARPU guidance, he further mentioned.
CMCSA Price Action: Shares of Comcast had risen by 1.13% to $33.63 at the time of publication on Friday.
Read More: • <a href="https://www.benzinga.com/general/entertainment/25/01/43150781/netflix-crushed-q4-thanks-to-sports-squid-game-says-gary-black-analyst-highlights-low-attrition-despite-price-hikes-predicts-stock-upside">Netflix Crushed Q4 Thanks To Sports, Squid Game, Says Gary Black: Analyst Highlights Low Attrition Despite Price Hikes, Predicts Stock Upside</a>
Photo: Shutterstock

Earnings Beats

Downgrades

CMCSA

Comcast Q4 Beat Overshadowed By Broadband Loss; Pain To Continue, Analysts Say

In a report released today, Eric Stine from Craig-Hallum assigned a Buy rating to Carbon Revolution (CREV – Research Report). The company's shares ...

Craig-Hallum Issues a Buy Rating on Carbon Revolution (CREV)

Carbon Revolution secures $25M financing agreement with Orion Infrastructure Capital

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!



Moving stocks this morning are earnings reports, a clinical trial update, acquisition news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing close to 121% <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">on a clinical trial update</a>.</li>



<li>BurgerFi International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) shares are soaring more than 93% <a href="https://www.nasdaq.com/press-release/burgerfi-reaches-legal-settlement-agreement-lion-point-capital-lp-2024-07-25">on a settlement agreement</a>.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is surging over 65% on a <a href="https://www.nasdaq.com/press-release/carbon-revolution-supplies-carbon-fiber-wheels-chevrolet-corvette-zr1-2024-07-25">supply deal with Chevrolet</a>.</li>



<li>Everi (NYSE:<a href="https://investorplace.com/stock-quotes/evri-stock-quote/">EVRI</a>) shares are gaining more than 35% <a href="https://www.nasdaq.com/press-release/igts-gaming-and-digital-business-and-everi-be-acquired-simultaneously-apollo-funds">on an acquisition deal</a>.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) stock is increasing over 26% with its <a href="https://www.businesswire.com/news/home/20240725452896/en/Coursera-Reports-Second-Quarter-2024-Financial-Results">latest earnings report</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are rising more than 24% alongside heavy pre-market trading.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is heading over 21% higher with strong early morning trading.</li>



<li>Nova Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVA#NASDAQ">NVA</a>) shares are climbing more than 20% <a href="https://www.tipranks.com/news/company-announcements/nova-minerals-issues-millions-of-new-warrants">after issuing new warrants</a>.</li>



<li>International Game Technology (NYSE:<a href="https://investorplace.com/stock-quotes/igt-stock-quote/">IGT</a>) stock is jumping over 20% alongside the <a href="https://www.prnewswire.com/news-releases/igts-gaming-and-digital-business-and-everi-to-be-acquired-simultaneously-by-apollo-funds-in-all-cash-transaction-302207429.html">Everi acquisition news</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are up more than 17% on Friday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is crashing more than 40% without any clear news this morning.</li>



<li>DexCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) shares are plummeting over 34% on <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">poor Q2 results and a cut outlook</a>.</li>



<li>Advent Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/adn-stock-quote/">ADN</a>) stock is diving more than 33% despite a lack of news this morning.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are tumbling over 30% after <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">rallying earlier this week</a>.</li>



<li>Zynex (NASDAQ:<a href="https://investorplace.com/stock-quotes/zyxi-stock-quote/">ZYXI</a>) stock is taking a nearly 23% beating with its <a href="https://www.nasdaq.com/press-release/zynex-reports-second-quarter-2024-financial-results-2024-07-25">Q2 earnings report</a>.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are sliding more than 22% <a href="https://www.nasdaq.com/press-release/ocean-power-technologies-inc-announces-fourth-quarter-and-full-year-fiscal-2024">alongside its latest earnings report</a>.</li>



<li>Renovaro (NASDAQ:<a href="https://investorplace.com/stock-quotes/renb-stock-quote/">RENB</a>) stock is dropping over 18% without any obvious news to report.</li>



<li>Avinger (NASDAQ:<a href="https://investorplace.com/stock-quotes/avgr-stock-quote/">AVGR</a>) shares are falling almost 15% this morning.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is decreasing 14% after rallying yesterday.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares close out our pre-market stock movers down more than 13.5% after jumping yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Automotive parts specialist Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) &ndash; which focuses on manufacturing carbon fiber (<a href="https://investorplace.com/stock-quotes/cf-stock-quote/">CF</a>) wheels for vehicle manufacturers &ndash; saw its shares pop dramatically higher on Friday. Last night, the company revealed that it will supply the CF wheels available on the upcoming (and just revealed) Chevrolet Corvette ZR1. Chevrolet is a General Motors (NYSE:<a href="https://investorplace.com/stock-quotes/gm-stock-quote/">GM</a>) brand and the credibility boost lifted CREV stock.



Carbon&rsquo;s CF wheels &ndash; designed as a one-piece framework &ndash; carries the advantage of being significantly lighter than the aluminum-wheel option. Per the accompanying <a href="https://finance.yahoo.com/news/carbon-revolution-supplies-carbon-fiber-011000695.html">press release</a>, the CF wheels will reduce the Corvette ZR1&rsquo;s rotating, unsprung mass by 42.8 pounds across the vehicle. While the underlying aesthetic appeal will likely be important, it may be the performance improvement that inspires prospective buyers.



After all, the Corvette isn&rsquo;t cheap. According to Kelley Blue Book, the base model Corvette carries an <a href="https://www.kbb.com/chevrolet/corvette/">MSRP of just under $70,000</a>. The current top-end model &ndash; the Z06 &ndash; commands an MSRP of $111,795. However, Car and Driver estimates that the upcoming ZR1 <a href="https://www.autonationdrive.com/blog/2019/october/15/essential-auto-101-what-is-a-halo-car.htm">halo car</a> (essentially the flagship that gets consumers excited about the underlying brand) will carry a price tag <a href="https://www.caranddriver.com/chevrolet/corvette-zr1">between $180,000 to $205,000</a>.



In other words, a consumer plunking that amount of cash for a vehicle will likely want the absolute best in performance: that&rsquo;s probably why CREV stock skyrocketed today.



<h2>CREV Stock Linked to a Groundbreaking Performance Vehicle</h2>



Per the press release, Carbon CEO Jake Dingle noted that the new ZR1 will be the third Corvette that features the company&rsquo;s CF wheels. &ldquo;Our team harnessed its extensive engineering and manufacturing experience to come up with a wheel befitting of the highest-performance Corvette we&rsquo;ve ever seen,&rdquo; the head executive remarked.



Dingle isn&rsquo;t kidding. According to MotorTrend, the Z06 rockets to 60 miles per hour (mph) from standstill in <a href="https://www.motortrend.com/reviews/2023-chevrolet-corvette-z06-convertible-0-60-quarter-mile-time/">just 2.6 seconds</a>. It eclipses the quarter mile in a blistering 10.6 seconds with a trap speed of 131.6 mph. That&rsquo;s supercar performance coming out of an engine that generates 670 horsepower.



On the other hand, Chevrolet has yet to release its figures for 0-60 times for the ZR1. But what has enthusiasts excited about the upcoming automotive juggernaut is that it generates 1,064 horsepower. To truly get the most out of this vehicle, prospective buyers will likely opt for the CF wheels. This dynamic has speculators bidding up CREV stock.



To be fair, the company is a risky proposition. Shortly following its initial public offering, CREV stock screamed higher to an <a href="https://finance.yahoo.com/quote/CREV/history/">intraday-record high of $197.99</a>. Still, the equity quickly fell back toward a more terrestrial range.



Nevertheless, with the announcement of the partnership with GM&rsquo;s high-performance halo car, investors may have Carbon Revolution on their watch list.



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/crev-stock-pops-as-carbon-revolution-snags-chevrolet-supply-deal/">CREV Stock Pops as Carbon Revolution Snags Chevrolet Supply Deal</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CREV Stock Pops as Carbon Revolution Snags Chevrolet Supply Deal

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!



Moving stocks this morning are clinical trial updates, an acquisition deal and a public offering.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Planet Image (NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock is rocketing more than 79% alongside heavy pre-market trading.</li>



<li>Lipella Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) shares are soaring over 58% after <a href="https://www.stocktitan.net/news/LIPO/lipella-pharmaceuticals-initiates-phase-2a-trial-for-lp-310-in-oral-kdvluw7gmnv7.html">initiating a Phase 2a clinical trial</a>.</li>



<li>Cognition Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgtx-stock-quote/">CGTX</a>) stock is surging more than 44% with <a href="https://www.nasdaq.com/press-release/cognition-therapeutics-proof-concept-phase-2-shine-trial-demonstrates-consistent">positive Phase 2 study results</a>.</li>



<li>Tivic Health Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/tivc-stock-quote/">TIVC</a>) shares are gaining over 32% following a <a href="https://www.nasdaq.com/press-release/bestgrowthstockscom-issues-comprehensive-analysis-tivic-health-systems-potential">breakdown of its potential catalysts</a>.</li>



<li>Longeveron (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) stock is increasing more than 22% with the release of <a href="https://www.nasdaq.com/press-release/longeveronr-presents-study-results-clear-mind-phase-2a-clinical-trial-lomecel-btm">Phase 2a study results</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are rising 22% without any clear news this morning.</li>



<li>Cepton (NASDAQ:<a href="https://investorplace.com/stock-quotes/cptn-stock-quote/">CPTN</a>) stock is climbing over 19% on <a href="https://www.stocktitan.net/news/CPTN/cepton-signs-definitive-agreement-to-be-acquired-by-7cwu0k4o8p93.html">an acquisition agreement</a>.</li>



<li>Ambipar Emergency (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ambi-stock-quote/">AMBI</a>) shares are jumping more than 18% this morning.</li>



<li>BurgerFi (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) stock is heading over 16% higher as it <a href="https://investorplace.com/2024/07/why-is-burgerfi-international-bfi-stock-up-71-today/">continues a recent rally</a>.</li>



<li>Vaccinex (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcnx-stock-quote/">VCNX</a>) shares are up more than 15% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>vTv Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtvt-stock-quote/">VTVT</a>) stock is plummeting over 44% after announcing the Food and Drug Administration&nbsp;(FDA) <a href="https://www.nasdaq.com/press-release/vtv-therapeutics-announces-cadisegliatin-program-type-1-diabetes-placed-clinical-hold">placed a clinical hold</a> on one of its trials.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) shares are diving more than 33% despite a lack of news this morning.</li>



<li>Treasure Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/tgl-stock-quote/">TGL</a>) stock is tumbling over 25% on Monday morning.</li>



<li>LuxUrban Hotels (NASDAQ:<a href="https://investorplace.com/stock-quotes/luxh-stock-quote/">LUXH</a>) shares are taking a more than 17% beating after <a href="https://www.globenewswire.com/news-release/2024/07/27/2919920/0/en/LuxUrban-Hotels-Announces-Pricing-of-Public-Offering-of-Securities.html">pricing a public offering</a>.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is dropping over 11% without any clear news to report.</li>



<li>Phio Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/phio-stock-quote/">PHIO</a>) shares are sliding more than 11% this morning.</li>



<li>Notable Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntbl-stock-quote/">NTBL</a>) stock is decreasing over 10% on Monday morning.</li>



<li>Regencell Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgc-stock-quote/">RGC</a>) shares are falling more than 9% after a Friday rally.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is slipping over 9% after jumping Friday <a href="https://finance.yahoo.com/news/carbon-revolution-supplies-carbon-fiber-011000695.html">on a wheels deal</a>.</li>



<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-29th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Carbon Revolution (CREV) announced that OIC has released an incremental $5M of the escrowed $35M facility, of which, as a result of this most recen...

Carbon Revolution secures further release of $5M from OIC

Carbon Revolution receives non-compliance letter from Nasdaq

Carbon Revolution Secures gets $25M financing

Stocks are cautiously lower after paring earlier losses.

Stocks Quietly Lower After Early Morning Plunge

Carbon Revolution (CREV) announced that Orion Infrastructure Capital has released an incremental $5M of the $25M facility announced on December 23,...

Carbon Revolution secures release of $5M from OIC, $0.4M reserve release

AMBI

BLMZ

CERO

CGTX

COUR

CPTN

DXCM

EVRI

INVO

KULR

LGVN

LIPO

LUXH

NMHI

NTBL

NUWE

OPTT

PAPL

PHIO

POET

RENB

SLNA

VCNX

VTVT

WINT

XCUR

YIBO

ZPTA

ZYXI

Financing

Press Releases

Carbon Revolution Secures $25 Million Financing Agreement with OIC to Fund Growth

Carbon Revolution Secures Further Release of $5 Million from OIC as Company Hits Financing Milestones

Carbon Revolution Supplies Carbon Fiber Wheels For Chevrolet Corvette ZR1

Carbon Revolution Secures Further Release of $5 Million from OIC as Company Launches Key Program

Carbon Revolution Supplies Carbon Fiber Wheels For Range Rover Sport SV Edition Two

Carbon Revolution Secures Further Release of $5 Million from OIC as Company Launches Key Programs

Carbon Revolution Secures Further Release of $5 Million from OIC

Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq

Carbon Revolution Secures New $25 Million Financing Agreement with OIC and Existing Lenders

Carbon Revolution Secures Further Release of $5 Million from OIC and further $0.4 Million Reserve Release from Existing Lenders

Craig-Hallum

Comments

Carbon Revolution

Noticias

Últimas noticias sobre Carbon Revolution (NASDAQ:CREV) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL